KIORA PHARMACEUTICALS INC Results of Operations and Financial Condition, Financial Statements and Exhibits - Marketscreener.com

NLBS Stock  USD 0.0001  0.00  0.00%   
Slightly above 56% of Nutralife Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Nutralife Biosciences pink sheet suggests that many investors are alarmed at this time. Nutralife Biosciences' investing sentiment can be driven by a variety of factors including economic data, Nutralife Biosciences' earnings reports, geopolitical events, and overall market trends.
Nutralife Biosciences pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nutralife daily returns and investor perception about the current price of Nutralife Biosciences as well as its diversification or hedging effects on your existing portfolios.
  
KIORA PHARMACEUTICALS INC Results of Operations and Financial Condition, Financial Statements and Exhibits Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Nutralife Biosciences Fundamental Analysis

We analyze Nutralife Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutralife Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutralife Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Nutralife Biosciences is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Peers

Trending Equities

BBY  3.50   
0%
100.0%
TGT  2.81   
0%
80.0%
UPS  2.63   
0%
75.0%
HD  2.33   
0%
66.0%
MET  1.64   
0%
46.0%
CVS  1.59   
0%
45.0%
WFC  1.51   
0%
43.0%
S  1.46   
0%
41.0%
C  1.29   
0%
36.0%
AAL  1.27   
0%
36.0%
T  0.87   
0%
24.0%
AAPL  0.59   
0%
16.0%
CVX  0.45   
0%
12.0%
IBM  0.26   
0%
7.0%
INTC  0.25   
0%
7.0%
AA  2.11   
60.0%
0%

Additional Tools for Nutralife Pink Sheet Analysis

When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.